OptimizeRx Corp (OPRX) Stock Forecast & Price Target

OptimizeRx is a strong player in the digital healthcare technology space, demonstrating consistent growth and profitability despite challenges from macro and company-specific issues. Their unique ability to deliver different types of messages directly in the provider's EHR sets them apart from competitors, and the recent programmatic connection with DSPs opens up a new supply-side access point for POC and point-of-prescribe inventory. While there may be some near-term headwinds, we anticipate that OptimizeRx will be able to continue to gain market share and grow revenue in the high teens/low twenties, while maintaining strong margins and efficient cost management.

OptimizeRx is facing several challenges including declining net revenue retention of 110%, which is 400 bps lower than the previous year due to execution issues with a top client, the impact of Most Favored Nation pricing, and continued economic uncertainty. The company has also lowered its revenue guidance by 13% for 2026 and has no managed services included, which could be a 9% headwind to growth. Additionally, there is low visibility on 2026 revenue compared to the previous quarter. These challenges, along with declining margins and negative free cash flow, suggest a deteriorating financial outlook for OptimizeRx.